Topic

Signifor / Signifor LAR (pasireotide)

A collection of 29 issues

Getting Signifor LAR (Pasireotide) Approved by Aetna in Virginia: Prior Authorization Guide and Appeal Process

Answer Box: Fast Track to Approval To get Signifor LAR (pasireotide) covered by Aetna in Virginia: Submit prior authorization with documented trial/failure of Somatuline Depot (lanreotide), elevated IGF-1 or cortisol labs, and surgical history via Aetna's precertification form. Appeals must be filed within 180 days, with Virginia

How to Get Signifor LAR (Pasireotide) Covered by Humana in Michigan: PA Forms, Appeals Timeline & Cost-Saving Strategies

Quick Answer: Getting Signifor LAR Covered by Humana in Michigan Signifor LAR (pasireotide) requires prior authorization from Humana for both Cushing's disease and acromegaly treatment. The fastest path to approval involves your endocrinologist submitting comprehensive biochemical documentation—elevated 24-hour urinary free cortisol (UFC) for Cushing's or

Get Signifor LAR (Pasireotide) Covered by Blue Cross Blue Shield in Florida: 2025 Prior Authorization Guide

Quick Answer: Your Path to Coverage Yes, Florida Blue covers Signifor LAR (pasireotide) for Cushing's disease and acromegaly, but requires prior authorization. The fastest path: ensure your endocrinologist has documented failed surgery or contraindications, recent labs (UFC for Cushing's, IGF-1 for acromegaly), and baseline tests within

Renewing Signifor / Signifor LAR (Pasireotide) Approval with Blue Cross Blue Shield in Illinois: 2025 Requirements & Timeline

Answer Box: Renewing Your Signifor Coverage in Illinois Signifor/Signifor LAR renewals with Blue Cross Blue Shield of Illinois require updated clinical documentation showing treatment response, typically every 12 months. Start your renewal 60-90 days before expiration to avoid coverage gaps. You'll need recent urinary free cortisol (UFC)

Getting Signifor LAR (Pasireotide) Covered by Blue Cross Blue Shield in Washington: Complete 2025 Coding, Prior Auth & Appeals Guide

Answer Box: Quick Path to Coverage To get Signifor LAR covered by Blue Cross Blue Shield in Washington: First, identify your specific carrier (Premera Blue Cross or Regence BlueShield). Submit prior authorization using ICD-10 code E24.0 (Cushing's disease) or E22.0 (acromegaly), HCPCS J2502 for billing, and

How to Get Signifor LAR (Pasireotide) Covered by Cigna in Florida: Appeals, Prior Authorization & Cost Assistance

Answer Box: Getting Signifor LAR Covered by Cigna in Florida Fastest path to approval: Submit prior authorization through CoverMyMeds or EviCore portal with complete endocrine labs (UFC for Cushing's, IGF-1 for acromegaly), specialist prescriber documentation, and evidence of prior therapy failures. Cigna classifies Signifor LAR as Tier 4

Blue Cross Blue Shield Ohio's Coverage Criteria for Signifor LAR (Pasireotide): What Counts as "Medically Necessary"?

Answer Box: Getting Signifor LAR Covered in Ohio Blue Cross Blue Shield Ohio requires prior authorization for Signifor LAR (pasireotide). To qualify, you need: (1) endocrinologist prescription, (2) documented Cushing's disease with elevated UFC levels OR acromegaly with failed first-generation somatostatin analogs, and (3) evidence that surgery isn&

Getting Signifor LAR (Pasireotide) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval UnitedHealthcare requires prior authorization for Signifor LAR (pasireotide) with specific criteria: confirmed endogenous Cushing's disease and documentation that pituitary surgery was non-curative or not viable. No step therapy required. Your board-certified endocrinologist must submit through OptumRx with biochemical proof (abnormal UFC or

Getting Signifor LAR (Pasireotide) Covered by Humana in Illinois: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Signifor LAR Covered by Humana in Illinois Eligibility: Signifor LAR (pasireotide) requires prior authorization from Humana for Cushing's disease (when surgery isn't an option/curative) and acromegaly (inadequately controlled after surgery/first-generation SSA failure). Fastest path: Submit comprehensive medical necessity documentation with biochemical

Lowering Out-of-Pocket Costs for Signifor LAR (Pasireotide) with UnitedHealthcare in Washington: Complete Guide to Copay Assistance, Tier Exceptions, and Appeals

Quick Answer: Lowering Your Signifor LAR Costs Signifor LAR (pasireotide) is a high-cost specialty medication typically placed on Tier 4-5 with UnitedHealthcare, meaning significant out-of-pocket costs. However, multiple cost-reduction strategies exist: 1. Apply for the Recordati copay card (commercial insurance only) - reduces copays to $20 for eligible patients 2.